title: [Approach to male breast cancer. Our experience].
abstract: Male breast cancer is a rare neoplasia and represents only 1% of all forms of breast cancer. The etiopathogenesis of breast carcinoma is still unknown in both males and females, but an altered hormonal metabolism may play a role in its genesis. The prognosis of breast cancer is slightly worse in males, especially in cases with axillary lymph node metastases. The paper discusses the therapy administered to 8 patients with male breast cancer who were treated by the authors between January 1983 and April 1990.
authors.affiliation: Cattedra di Chirurgia Generale, Università degli Studi, Messina.
authors.forename: F
authors.initials: F
authors.lastname: Lemma
authors.forename: S
authors.initials: S
authors.lastname: Straci
authors.forename: U
authors.initials: U
authors.lastname: Torchia
authors.forename: M
authors.initials: M
authors.lastname: Milici
authors.forename: M
authors.initials: M
authors.lastname: Saitta
authors.forename: O
authors.initials: O
authors.lastname: Geraci
authors.forename: A
authors.initials: A
authors.lastname: Querci
mesh_terms: D000367:Age Factors; D018567:Breast Neoplasms, Male / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D015411:Mastectomy, Modified Radical; D015413:Mastectomy, Simple; D008875:Middle Aged; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D013997:Time Factors